Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bessy Benejam

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Nature Communications|July 2, 2025
Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s diseaseLaia Montoliu-Gaya, Shijia Bian, Eric B Dammer, et al.
Journal of Alzheimer'S Disease : JAD|May 10, 2021
The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further ValidationAlain D Dekker, Aurora M Ulgiati, Henk Groen, et al.
Brain : a Journal of Neurology|April 17, 2025
Medial temporal lobe atrophy in Down syndrome along the Alzheimer's disease continuumBenjamin J Buehner, Alejandra O Morcillo-Nieto, Sara E Zsadanyi, et al.
Frontiers in Aging Neuroscience|July 6, 2026
The predictive power of neuropsychological measures in MCI: early detection of dementia conversionConcepcion Padilla, Sara E Zsadanyi, Irina Aragón, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 18, 2025
Alpha-synuclein co-pathology in Down syndrome-associated Alzheimer's diseaseAlexander Maximilian Bernhardt, Íñigo Rodríguez-Baz, Iban Aldecoa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 29, 2026
Peak width of skeletonized mean diffusivity reveals early and multifactorial white matter injury across sporadic and Down syndrome-associated Alzheimer's diseaseAlejandra O Morcillo-Nieto, Maria Franquesa-Mullerat, Sara E Zsadanyi, et al.
JAMA Neurology|July 6, 2021
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down SyndromeAlexandre Bejanin, Maria Florencia Iulita, Eduard Vilaplana, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium studyPhoebe Ivain, Asaad Baksh, Fedal Saini, et al.
Brain Communications|April 14, 2023
Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndromeM Florencia Iulita, Alexandre Bejanin, Eduard Vilaplana, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2019
The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disordersDaniel Alcolea, Jordi Clarimón, María Carmona-Iragui, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Nature Communications|July 2, 2025
Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s diseaseLaia Montoliu-Gaya, Shijia Bian, Eric B Dammer, et al.
Journal of Alzheimer'S Disease : JAD|May 10, 2021
The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further ValidationAlain D Dekker, Aurora M Ulgiati, Henk Groen, et al.
Brain : a Journal of Neurology|April 17, 2025
Medial temporal lobe atrophy in Down syndrome along the Alzheimer's disease continuumBenjamin J Buehner, Alejandra O Morcillo-Nieto, Sara E Zsadanyi, et al.
Frontiers in Aging Neuroscience|July 6, 2026
The predictive power of neuropsychological measures in MCI: early detection of dementia conversionConcepcion Padilla, Sara E Zsadanyi, Irina Aragón, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 18, 2025
Alpha-synuclein co-pathology in Down syndrome-associated Alzheimer's diseaseAlexander Maximilian Bernhardt, Íñigo Rodríguez-Baz, Iban Aldecoa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 29, 2026
Peak width of skeletonized mean diffusivity reveals early and multifactorial white matter injury across sporadic and Down syndrome-associated Alzheimer's diseaseAlejandra O Morcillo-Nieto, Maria Franquesa-Mullerat, Sara E Zsadanyi, et al.
JAMA Neurology|July 6, 2021
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down SyndromeAlexandre Bejanin, Maria Florencia Iulita, Eduard Vilaplana, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium studyPhoebe Ivain, Asaad Baksh, Fedal Saini, et al.
Brain Communications|April 14, 2023
Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndromeM Florencia Iulita, Alexandre Bejanin, Eduard Vilaplana, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2019
The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disordersDaniel Alcolea, Jordi Clarimón, María Carmona-Iragui, et al.
Pageof 8